4//SEC Filing
Monia Brett P 4
Accession 0000874015-25-000221
CIK 0000874015other
Filed
Sep 3, 8:00 PM ET
Accepted
Sep 4, 8:38 PM ET
Size
22.9 KB
Accession
0000874015-25-000221
Insider Transaction Report
Form 4
Monia Brett P
DirectorChief Executive Officer
Transactions
- Exercise/Conversion
Common Stock
2025-09-03$53.77/sh+102,900$5,532,933→ 282,909 total - Sale
Common Stock
2025-09-03$59.12/sh−16,615$982,262→ 266,294 total - Exercise/Conversion
Common Stock
2025-09-03$32.60/sh+27,568$898,717→ 239,708 total - Exercise/Conversion
Non-Qualified Stock Option (right to buy)
2025-09-03−27,568→ 40,173 totalExercise: $32.60From: 2023-01-03Exp: 2032-01-02→ Common Stock (27,568 underlying) - Exercise/Conversion
Common Stock
2025-09-03$32.60/sh+31,316$1,020,902→ 212,140 total - Sale
Common Stock
2025-09-03$61.06/sh−59,699$3,645,394→ 180,009 total - Exercise/Conversion
Non-Qualified Stock Option (right to buy)
2025-09-03−31,316→ 67,741 totalExercise: $32.60From: 2023-01-03Exp: 2032-01-02→ Common Stock (31,316 underlying) - Exercise/Conversion
Non-Qualified Stock Option (right to buy)
2025-09-03−42,030→ 76,643 totalExercise: $37.58From: 2024-01-03Exp: 2033-01-02→ Common Stock (42,030 underlying) - Exercise/Conversion
Non-Qualified Stock Option (right to buy)
2025-09-03−102,900→ 0 totalExercise: $53.77From: 2020-01-02Exp: 2026-01-01→ Common Stock (102,900 underlying) - Exercise/Conversion
Common Stock
2025-09-03$37.58/sh+42,030$1,579,487→ 308,324 total - Sale
Common Stock
2025-09-03$60.13/sh−127,500$7,667,047→ 180,824 total
Footnotes (4)
- [F1]Shares sold pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on August 13, 2024.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $58.57 to $59.55 inclusive. The reporting person undertakes to provide to Ionis Pharmaceuticals, Inc. any security holder of Ionis Pharmaceuticals, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) on this Form 4.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $59.60 to $60.57 inclusive. The reporting person undertakes to provide to Ionis Pharmaceuticals, Inc. any security holder of Ionis Pharmaceuticals, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (3) on this Form 4.
- [F4]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $60.61 to $61.48 inclusive. The reporting person undertakes to provide to Ionis Pharmaceuticals, Inc. any security holder of Ionis Pharmaceuticals, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (4) on this Form 4.
Documents
Issuer
IONIS PHARMACEUTICALS INC
CIK 0000874015
Entity typeother
Related Parties
1- filerCIK 0001537529
Filing Metadata
- Form type
- 4
- Filed
- Sep 3, 8:00 PM ET
- Accepted
- Sep 4, 8:38 PM ET
- Size
- 22.9 KB